Core Viewpoint - Aehr Test Systems experienced a boost in share price due to new orders for AI processor diagnostic products, which helped overshadow a disappointing quarterly earnings report [1] Group 1: New Orders - Aehr received over $5.5 million in orders for its Sonoma AI diagnostic systems from multiple customers, described as "leading-edge AI companies" and a "premier Bay Area lab" [2] - The current quarter's orders for Sonoma already exceed the total for the entire previous quarter [3] Group 2: Financial Performance - For the second quarter of fiscal 2026, Aehr's net revenue decreased to $9.9 million from $13.5 million year-over-year [4] - The company reported a net loss of $1.3 million, or $0.04 per share, compared to a profit of $700,000 in the same period last year [4] Group 3: Future Guidance - Aehr reinstated its revenue guidance, expecting between $25 million to $30 million in revenue and a non-GAAP net loss of $0.05 to $0.09 per share for the second half of the fiscal year [5]